1. Home
  2. MRX vs PRCT Comparison

MRX vs PRCT Comparison

Compare MRX & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRX
  • PRCT
  • Stock Information
  • Founded
  • MRX 2005
  • PRCT 2009
  • Country
  • MRX United Kingdom
  • PRCT United States
  • Employees
  • MRX N/A
  • PRCT N/A
  • Industry
  • MRX
  • PRCT Medical Specialities
  • Sector
  • MRX
  • PRCT Health Care
  • Exchange
  • MRX NYSE
  • PRCT Nasdaq
  • Market Cap
  • MRX 3.3B
  • PRCT 3.2B
  • IPO Year
  • MRX 2024
  • PRCT 2021
  • Fundamental
  • Price
  • MRX $43.16
  • PRCT $58.00
  • Analyst Decision
  • MRX Strong Buy
  • PRCT Strong Buy
  • Analyst Count
  • MRX 6
  • PRCT 7
  • Target Price
  • MRX $42.17
  • PRCT $90.00
  • AVG Volume (30 Days)
  • MRX 1.2M
  • PRCT 850.8K
  • Earning Date
  • MRX 05-15-2025
  • PRCT 04-24-2025
  • Dividend Yield
  • MRX 1.39%
  • PRCT N/A
  • EPS Growth
  • MRX N/A
  • PRCT N/A
  • EPS
  • MRX 3.09
  • PRCT N/A
  • Revenue
  • MRX $2,529,500,000.00
  • PRCT $249,121,000.00
  • Revenue This Year
  • MRX N/A
  • PRCT $47.40
  • Revenue Next Year
  • MRX $8.26
  • PRCT $31.81
  • P/E Ratio
  • MRX $13.98
  • PRCT N/A
  • Revenue Growth
  • MRX 36.81
  • PRCT 59.36
  • 52 Week Low
  • MRX $18.13
  • PRCT $47.04
  • 52 Week High
  • MRX $49.34
  • PRCT $103.81
  • Technical
  • Relative Strength Index (RSI)
  • MRX N/A
  • PRCT 54.16
  • Support Level
  • MRX N/A
  • PRCT $55.18
  • Resistance Level
  • MRX N/A
  • PRCT $59.06
  • Average True Range (ATR)
  • MRX 0.00
  • PRCT 2.64
  • MACD
  • MRX 0.00
  • PRCT 0.16
  • Stochastic Oscillator
  • MRX 0.00
  • PRCT 78.08

About MRX MAREX GROUP PLC

Marex Group PLC offers a diversified financial services platform providing essential liquidity, market access, and infrastructure services to clients across energy, commodities, and financial markets. It provides critical services to the clients by connecting them to exchanges and providing various execution and hedging services across its assets and products. The group operates in a large and fragmented market with infrastructure requirements and regulatory and technological complexity. It has five segments Clearing, Agency and Execution, Market Making, Hedging and Investment Solutions, and The Corporate. The group generates revenue from Agency and Execution that matches buyers and sellers by facilitating price discovery across the energy and financial securities markets.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: